Alice Cheung

Title: The Innovative Contributions of Alice Cheung

Introduction

Alice Cheung is a prominent inventor based in Belfast, GB. She has made significant strides in the field of medical diagnostics, particularly concerning pregnancy-related health issues. Her work focuses on the development of innovative solutions that can improve maternal and fetal health outcomes.

Latest Patents

Alice Cheung holds a patent for a groundbreaking invention titled "Biomarker for Preeclampsia." This invention relates to the use of the biomarker LRG1 as a predictive tool for preeclampsia, applicable from the first trimester of pregnancy. Elevated levels of leucine-rich alpha 2 glycoprotein 1 (LRG1) can indicate the risk of developing preeclampsia or other hypertensive disorders during pregnancy. The predictive test involves measuring LRG1 protein, peptide fragments, DNA, or RNA from various biological samples, including blood, plasma, serum, urine, saliva, or amniotic fluid. This invention provides a method and a test kit to assess the risk of pre-eclampsia in pregnant women, utilizing antibodies to measure levels of LRG1 in a sample. Alice has 1 patent to her name.

Career Highlights

Alice Cheung is affiliated with The Queen's University of Belfast, where she contributes to research and innovation in the field of maternal health. Her work has garnered attention for its potential to transform prenatal care and improve health outcomes for mothers and their babies.

Collaborations

Alice has collaborated with notable colleagues, including Chris Watson and Timothy Lyons, to advance her research and develop her innovative solutions. Their combined expertise has played a crucial role in the success of her projects.

Conclusion

Alice Cheung's contributions to the field of medical diagnostics, particularly through her patent on the biomarker for preeclampsia, highlight her commitment to improving maternal health. Her work exemplifies the impact of innovation in addressing critical health challenges faced by pregnant women.